ArticleTranslational lung cancer research2026
Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction model.
Hao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.